Quality by Design for Analytical Methods: Implications for Method Validation and Transfer - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Quality by Design for Analytical Methods: Implications for Method Validation and Transfer
The authors describe how traditional approaches to analytical method and validation may benefit from alignment with quality-by-design concepts.


Pharmaceutical Technology
Volume 36, Issue 10, pp. 74-79

References

1. P. Nethercote, et al., "QbD for Better Method Validation and Transfer," Pharmamanuf. online, http://www.pharmamanufacturing.com/articles/2010/060.html, accessed June 10, 2012.

2. FDA, Pharmaceutical cGMPs for the 21st Century—A Risk-Based Approach (Rockville, MD, 2004).

3. FDA, Guidance for Industry—Process Validation: General Principles and Practices (Rockville, MD, Jan. 2011).

4. M. Nasr, presentation at the AAPS Workshop (North Bethesda, MD, Oct. 5, 2005).

5. ICH, Q2(R1), Validation of Analytical Procedures: Text and Methodology, Step 4 version (2005).

6. P. Borman, et al., Pharm. Tech., 31 (10), 142–152 (2007).

7. USP General Chapter <1058>, "Analytical Instrument Qualification."

8. J. Ermer and J.S. Landy, "Validation of analytical procedures," in Encyclopedia of Pharmaceutical Technology, J. Swarbrick and J.C. Boylan, Eds. (Dekker, New York, 2nd ed., 2002), pp. 507–528.

9. ICH, Q8, Pharmaceutical Development (2009).

10. M. Schweitzer, et al., Pharm. Tech., 34(2), 52–59 (2010).

11. P.J. Borman, et al., Anal. Chim. Acta., 703(2), 101–113 (2011).

12. J. Ermer, et al., J. Pharm. Biomed. Anal., 38(4) 653–663 (2005).

13. USP General Chapter <1010>, "Analytical Data Interpretation & Treatment."

14. ICH, Q9, Quality Risk Management (2005).

15. ICH, Q10, Pharmaceutical Quality System (2008).

16. E. Ciurczak, "ICH Guidances (Already) Show Their Age," http://www.pharmamanufacturing.com/articles/2008/158.html, accessed June 10, 2012.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
25%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
11%
Regulatory compliance
36%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans
Source: Pharmaceutical Technology,
Click here